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Abstract
56 adults with type 2 diabetes received feedback on their actual risk for five diabetes complications, with half
receiving additional goal setting support. Outcome measures were collected at baseline and 9 months. HbA1c and
diabetes-related distress both improved, with reductions in distress associated with improvements in glycaemic
control (r=0.33, p=0.014).
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Introduction
Despite increasing awareness of diabetes-related complications and
availability of effective treatments, a substantial number of people with
diabetes have biomedical parameters (hyperlipidaemia, hypertension,
and hyperglycaemia) outside the recommended target range [1,2]. One
explanation for this may be sub-optimal diabetes self-management
[3,4].
Interventions to improve self-care are based typically on the
premise that individuals do not take their diabetes seriously enough or
that they do not believe themselves to be susceptible. This may be true
for some, however, evidence suggests the reverse may be true for
many. That is, people overestimate the likelihood that they will
develop diabetes-related complications [5-7]. For instance, of adults
with an HbA1c >64 mmol/mol (>8.0%), 56% and 48% overestimated
their risk of myocardial infarction and stroke by more than 20% [8].
This can lead to a sense of fatalism, resignation and distress. The
literature is replete with studies describing these characteristics among
people with diabetes [9,10], with recent research showing distress is
strongly associated with sub-optimal self-care and metabolic outcomes
[11,12].
Our hypothesis was that providing people with accurate
information about their risk of developing diabetes-related
complications, along with counselling on how they can meaningfully
reduce these risks, will encourage people to self-manage their diabetes
more effectively and reduce their risks.
Materials and Methods
Having obtained local research ethics approval, participants were
recruited from four general practices in rural Western Australia into a
pilot trial, using the following inclusion criteria: adults with type 2
diabetes, aged 40-70 years, an HbA1c ≥64 mmol/mol (≥8.0%), and one
or more additional risks: BP ≥140/80, total cholesterol >4 mmol/l, or a
current smoker. An invitation letter and information sheet were sent
to potential participants. General practitioner (GP) records provided
medical information needed for the risk profiling. Following collection
of baseline data, participants were randomised, using a computer-
generated random number. Follow-up data were collected at 9
months.
All participants received an Accu-Chek Mellibase® potential risk
report (Figure 1) and an explanation during a face-to-face
consultation, together with negotiation of options for change
culminating in the development of an initial self-management goal
[13]. This tool provides personalized risk information for five
complications (heart disease, stroke, amputation, retinopathy and
kidney failure), and indicates which risk factors have greatest impact
on risk reduction. It provides both absolute and relative risk reduction
information, and the risk, if treatment targets are achieved. Half the
participants also received a follow-up telephone call two weeks later
and telephone consultations at 3 and 6 months, with all having a face-
to-face consult at 9 months.
Measures and Analysis
At baseline, all participants completed study questionnaires,
providing: basic demographic and medical information; the Centre for
Epidemiological Studies Depression scale, a well validated, 20-item,
self-report measure of depressive symptomatology [14]; and the
Problem Areas in Diabetes scale, a well validated 20-item, self-report
measure of diabetes-related distress [15]. Biomedical data were
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obtained from the GP records at baseline, with 9-month data collected
by sending out reminders to patients to attend pathology
appointments and a final consultation. All pathology testing was
conducted by the same laboratory.
All data were analysed using an intention-to-treat analysis, with
missing data at 9 months imputed using baseline observation carried
forward. Analysis of variance was used to examine between-group and
within-group differences. Pearson’s correlation was used to examine
relationships between changes in HbA1c and diabetes-related distress.
Figure 1: Sample of Part of Risk Report
Results
Fifty-six participants were recruited: 54% men; mean age 59.3 (SD
11.3) years; 54% had completed only year 10 schooling and 13% had
completed a university degree; 13% were current smokers. 29 were
allocated randomly to receive additional follow-up. There were no
statistically significant differences between intervention and control
groups at baseline (Table 1).
There was a statistically significant reduction over time in HbA1c
(F=11.16, df=1, p=0.002) and diabetes-related distress (F=4.24, df=1,
p=0.044) for all participants, with a trend towards a greater reduction
in the intervention (Table 1). Overall, there was a trend for a small
reduction in body mass index (F=3.02, df=1, p=0.088) but no
statistically significant difference between groups. For those with
above target lipids (61%), there was a statistically significant reduction
over time (F=6.23, df=1, p=0.018) but no significant difference
between groups. For those with established hypertension (38%), there
was no statistically significant effect on systolic or diastolic blood
pressure. Greater reductions in diabetes-related distress were
associated with greater reductions in HbA1c (r=0.33, p=0.014).
Discussion
This pilot study sought to explore the feasibility and impact of
providing actual, personalised risk profiles and counselling on the
metabolic outcomes of adults with type 2 diabetes. Feasibility was
clearly demonstrated, with all individuals understanding the risk tool
and using the tool to develop specific plans for their diabetes
management. The potential impact was also demonstrated, with
participation in the study associated with statistically significant
reductions in HbA1c and diabetes distress, and for those above target,
in cholesterol, regardless of whether follow-up telephone counselling
was provided.
The main issue is whether the significant improvements in HbA1c,
cholesterol and diabetes-related distress seen in both groups can be
attributed to the provision of the personalised risk information or to
common Hawthorne effects. Our feasibility study design does not
allow us to answer this question but it does point to the need to
conduct a fully powered randomised controlled trial to determine if
feedback of actual personalised risk information alone engages people
to be more pro-active in managing their diabetes. The correlation
between change in HbA1c and diabetes-related distress is also of note.
This supports recent studies indicating that diabetes-related distress is
a key potential driver of glycaemic control [10,11,14].
Conclusions
Our primary aim was to test the feasibility of providing adults with
type 2 diabetes with accurate personalised information about their risk
of developing diabetes-related complications. This was, indeed,
feasible, did not increase diabetes-related distress, and is likely to be
viable for delivery within routine primary care. Our data suggest that a
full randomised trial is warranted to determine the impact of actual
personalised risk information on diabetes outcomes.
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HbA1c: mmol/mol 73.0(12.0) 69.0 (16.4) 75.0 (9.8) 68.0 (16.4) .002 .490
HbA1c: % 8.8 (1.1) 8.5 (1.5) 9.0 (0.9) 8.4 (1.5) .002 .490
BMI 33.5 (5.2) 33.0 (5.1) 34.0 (5.7) 33.8 (5.4) .088 .437
Systolic BP 134.7(19.5) 137.0(22.0) 135.6(20.0) 137.0(20.0) .479 .766
Diastolic BP 76.8 (9.1) 75.0(14.0) 78.6 (12.3) 80.0(13.0) .957 .186
Total cholesterol 4.7 (1.3) 4.5 (1.2) 4.2 (0.9) 4.0 (1.0) .222 .957
HDL cholesterol 1.2 (0.4) 1.2 (0.5) 1.0 (0.2) 1.1 (0.3) .239 .671
LDL cholesterol 2.5 (0.8) 2.7 (1.0) 2.3 (0.7) 2.1 (0.7) .567 .292
Depression (CES-D) 18 (15) 15 (15) 9 (11) 10 (12) .441 .228
Diabetes-related distress
(PAID)
21 (16) 17(13) 14 (10) 14 (11) .044 .090
Table 1: Comparison of study outcome measures (Mean and SD) between intervention and control groups at baseline and 9-month follow-up.
P value for main effect of time for both groups
P value for group by time interaction effect
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